Candel Therapeutics (CADL) Change in Account Payables (2020 - 2023)
Historic Change in Account Payables for Candel Therapeutics (CADL) over the last 4 years, with Q4 2023 value amounting to $172000.0.
- Candel Therapeutics' Change in Account Payables rose 13161.76% to $172000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $45000.0, marking a year-over-year increase of 10370.98%. This contributed to the annual value of -$185000.0 for FY2024, which is 51111.11% down from last year.
- According to the latest figures from Q4 2023, Candel Therapeutics' Change in Account Payables is $172000.0, which was up 13161.76% from -$214000.0 recorded in Q3 2023.
- Candel Therapeutics' 5-year Change in Account Payables high stood at $818000.0 for Q3 2020, and its period low was -$579000.0 during Q1 2022.
- Moreover, its 4-year median value for Change in Account Payables was $43500.0 (2023), whereas its average is -$15642.9.
- Per our database at Business Quant, Candel Therapeutics' Change in Account Payables soared by 22360.59% in 2021 and then plummeted by 43468.21% in 2022.
- Candel Therapeutics' Change in Account Payables (Quarter) stood at -$538000.0 in 2020, then soared by 223.61% to $665000.0 in 2021, then tumbled by 181.8% to -$544000.0 in 2022, then soared by 131.62% to $172000.0 in 2023.
- Its Change in Account Payables stands at $172000.0 for Q4 2023, versus -$214000.0 for Q3 2023 and -$62000.0 for Q2 2023.